NewAmsterdam Pharma Company N.V. Depreciation And Amortization for the Trailing 12 Months (TTM) ending December 31, 2024: USD 110.66 K

NewAmsterdam Pharma Company N.V. Depreciation And Amortization is USD 110.66 K for the Trailing 12 Months (TTM) ending December 31, 2024, a 144.67% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • NewAmsterdam Pharma Company N.V. Depreciation And Amortization for the Trailing 12 Months (TTM) ending December 31, 2023 was USD 45.23 K.
  • NewAmsterdam Pharma Company N.V. Depreciation And Amortization for the Trailing 12 Months (TTM) ending December 31, 2021 was USD 14.00 K.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased